Taysha Gene Therapies annual revenue
2022
2023
2024
2025
Taysha Gene Therapies Revenue Growth & History (TSHA)
Taysha Gene Therapies reported $9.8M in revenue for fiscal 2025, an increase of 17.28% from the previous fiscal year.
View full Taysha Gene Therapies company overviewTaysha Gene Therapies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.8M | $1.4M | +17.28% |
| 2024 | 2024-12-31 | $8.3M | −$7.1M | −46.07% |
| 2023 | 2023-12-31 | $15.5M | $12.9M | +517.55% |
| 2022 | 2022-12-31 | $2.5M | — | — |
Taysha Gene Therapies quarterly revenue
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$2.0M | −100.00% |
| Q1 2026 | 2026-03-31 | $0 | −$2.3M | −100.00% |
| Q4 2025 | 2025-12-31 | $5.5M | $3.5M | +171.27% |
| Q3 2025 | 2025-09-30 | $0 | −$1.8M | −100.00% |
| Q2 2025 | 2025-06-30 | $2.0M | $874,000 | +78.60% |
| Q1 2025 | 2025-03-31 | $2.3M | −$1.1M | −32.51% |
| Q4 2024 | 2024-12-31 | $2.0M | −$1.6M | −43.90% |
| Q3 2024 | 2024-09-30 | $1.8M | −$3.0M | −62.33% |
| Q2 2024 | 2024-06-30 | $1.1M | −$1.3M | −53.57% |
| Q1 2024 | 2024-03-31 | $3.4M | −$1.3M | −27.52% |
| Q4 2023 | 2023-12-31 | $3.6M | — | — |
| Q3 2023 | 2023-09-30 | $4.7M | — | — |
| Q2 2023 | 2023-06-30 | $2.4M | — | — |
| Q1 2023 | 2023-03-31 | $4.7M | — | — |
Taysha Gene Therapies revenue growth trends
Taysha Gene Therapies's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Taysha Gene Therapies source filings ↗